Literature DB >> 18945990

Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts.

Ivan D Maya1, Jeremy C O'Neal, Carlton J Young, Jill Barker-Finkel, Michael Allon.   

Abstract

BACKGROUND AND OBJECTIVES: An upper arm vascular access is often placed in patients with a failed forearm fistula or with vessels unsuitable for a forearm fistula. The aim of this study was to compare the outcomes of three upper arm access types: brachiocephalic fistulas, transposed brachiobasilic fistulas, and grafts. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A prospective, computerized access database was queried retrospectively to identify the clinical outcomes of upper arm accesses placed in 678 patients at a large dialysis center, including 322 brachiocephalic fistulas, 67 brachiobasilic fistulas, and 289 grafts.
RESULTS: Primary access failures were less common for brachiobasilic fistulas and grafts compared with brachiocephalic fistulas (18%, 15%, and 38%; hazard ratio of brachiocephalic fistulas versus brachiobasilic fistulas 2.76; 95% confidence interval 1.41 to 5.38; P < 0.003). For the subset of patients receiving a brachiocephalic fistula, a multiple variable logistic regression analysis including age, sex, race, diabetes, coronary artery disease, peripheral vascular disease, cerebrovascular disease, prior access, surgeon, arterial diameter, and venous diameter found that only vascular diameters predicted primary failure (P < 0.001). When primary failures were excluded, cumulative access survival was similar for brachiobasilic and brachiocephalic fistulas, but superior to that of grafts. Total access interventions per year were lower for brachiobasilic and brachiocephalic fistulas than for grafts (0.84, 0.82, and 1.87, respectively, P < 0.001).
CONCLUSIONS: Transposed brachiobasilic fistulas may be preferred, due to (1) a lower primary failure rate (similar to grafts), and (2) a lower intervention rate (similar to brachiocephalic fistulas). However, this advantage must be balanced against the more complex surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18945990      PMCID: PMC2615695          DOI: 10.2215/CJN.02910608

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  US vascular mapping before hemodialysis access placement.

Authors:  M L Robbin; M H Gallichio; M H Deierhoi; C J Young; T M Weber; M Allon
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

2.  Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.

Authors:  Zipporah Krishnasami; Donna Carlton; Lisa Bimbo; Maria E Taylor; Daniel F Balkovetz; Jill Barker; Michael Allon
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  Clinical consequences of infected arteriovenous grafts in hemodialysis patients.

Authors:  T E Minga; K H Flanagan; M Allon
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

4.  Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas.

Authors:  M J Oliver; R L McCann; O S Indridason; D W Butterly; S J Schwab
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

5.  Vascular access stenosis: comparison of arteriovenous grafts and fistulas.

Authors:  Ivan D Maya; Rachel Oser; Souheil Saddekni; Jill Barker; Michael Allon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

6.  Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients.

Authors:  M Allon; M E Lockhart; R Z Lilly; M H Gallichio; C J Young; J Barker; M H Deierhoi; M L Robbin
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

7.  Vein transposition in the forearm for autogenous hemodialysis access.

Authors:  M B Silva; R W Hobson; P J Pappas; P B Haser; C T Araki; M C Goldberg; Z Jamil; F T Padberg
Journal:  J Vasc Surg       Date:  1997-12       Impact factor: 4.268

Review 8.  Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

9.  Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen.

Authors:  Christopher V Poole; Donna Carlton; Lisa Bimbo; Michael Allon
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

10.  Hemodialysis arteriovenous fistula maturity: US evaluation.

Authors:  Michelle L Robbin; Nathan E Chamberlain; Mark E Lockhart; Michael H Gallichio; Carlton J Young; Mark H Deierhoi; Michael Allon
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

View more
  23 in total

1.  Statin therapy is not associated with improved vascular access outcomes.

Authors:  Roberto Pisoni; Jill Barker-Finkel; Michael Allo
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

Review 2.  New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients?

Authors:  Karen Woo; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

Review 3.  Arteriovenous Grafts: Much Maligned But in Need of Reconsideration?

Authors:  Michael Allon
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

4.  Association of Preexisting Arterial Intimal Hyperplasia with Arteriovenous Fistula Outcomes.

Authors:  Michael Allon; Silvio H Litovsky; Yingying Zhang; Ha Le; Alfred K Cheung; Yan-Ting Shiu
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-23       Impact factor: 8.237

5.  Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter.

Authors:  Timothy Copeland; Peter Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

6.  Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients.

Authors:  Mireille El Ters; Gregory J Schears; Sandra J Taler; Amy W Williams; Robert C Albright; Bernice M Jenson; Amy L Mahon; Andrew H Stockland; Sanjay Misra; Scott L Nyberg; Andrew D Rule; Marie C Hogan
Journal:  Am J Kidney Dis       Date:  2012-06-15       Impact factor: 8.860

7.  Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation.

Authors:  Michael Allon; Silvio Litovsky; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Michelle L Robbin
Journal:  Am J Kidney Dis       Date:  2011-06-30       Impact factor: 8.860

8.  Who should be referred for a fistula? A survey of nephrologists.

Authors:  Wang Xi; Jennifer MacNab; Charmaine E Lok; Timmy C Lee; Ivan D Maya; Michele H Mokrzycki; Louise M Moist
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

9.  Cumulative patency of contemporary fistulas versus grafts (2000-2010).

Authors:  Charmaine E Lok; Jessica M Sontrop; George Tomlinson; Dheeraj Rajan; Mark Cattral; George Oreopoulos; Jeremy Harris; Louise Moist
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

10.  Outcomes of arteriovenous fistulas and grafts with or without intervention before successful use.

Authors:  James C Harms; Sunil Rangarajan; Carlton J Young; Jill Barker-Finkel; Michael Allon
Journal:  J Vasc Surg       Date:  2016-04-08       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.